1207166-52-6

Basic information

• Product Name: 3-benzoylamino-3-phenyl-2-triethylsilanyloxy-propionic acid 14,20-bis(tert-butyl-dimethyl-silanyloxy)-8-hydroxy-7,13,15,17,19,21-hexamethyl-22-(1-methyl-penta-2,4-dienyl)-2-oxo-oxacyclodocosa-3,5,11,16-tetraen-10-yl ester
• CAS NO: 1207166-52-6
• Molecular Weight: 1154.84
• Mol File: 1207166-52-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-benzoylamino-3-phenyl-2-triethylsilanyloxy-propionic acid 14,20-bis(tert-butyl-dimethyl-silanyloxy)-8-hydroxy-7,13,15,17,19,21-hexamethyl-22-(1-methyl-penta-2,4-dienyl)-2-oxo-oxacyclodocosa-3,5,11,16-tetraen-10-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-benzoylamino-3-phenyl-2-triethylsilanyloxy-propionic acid 14,20-bis(tert-butyl-dimethyl-silanyloxy)-8-hydroxy-7,13,15,17,19,21-hexamethyl-22-(1-methyl-penta-2,4-dienyl)-2-oxo-oxacyclodocosa-3,5,11,16-tetraen-10-yl ester(1207166-52-6)
• EPA Substance Registry System: 3-benzoylamino-3-phenyl-2-triethylsilanyloxy-propionic acid 14,20-bis(tert-butyl-dimethyl-silanyloxy)-8-hydroxy-7,13,15,17,19,21-hexamethyl-22-(1-methyl-penta-2,4-dienyl)-2-oxo-oxacyclodocosa-3,5,11,16-tetraen-10-yl ester(1207166-52-6)

Safety Data

• Hazardous Substances Data: 1207166-52-6(Hazardous Substances Data)

Upstream product

• 373645-86-4 (5Z,13Z)-(2R,3R,4S,8S,9R,10R,11S,12S)-3,9-bis(tertbutyldimethylsilanyloxy)-11-hydroxy-2,4,6,8,10,12-hexamethylhexadeca-5,13,15-trienal 
• 1082395-61-6 C₄₈H₈₆O₇Si₂ 
• 1082395-55-8 C₄₅H₈₃IO₅Si₂ 
• 1082395-60-5 C₄₂H₇₉IO₅Si₂ 
• 1082395-59-2 C₄₂H₇₇IO₅Si₂ 
• 1082395-54-7 C₅₀H₈₅IO₆Si₂ 
• 1207166-37-7 14,20-bis(tert-butyl-dimethyl-silanyloxy)-8,10-dihydroxy-7,13,15,17,19,21-hexamethyl-22-(1-methyl-penta-2,4-dienyl)-oxacyclodocosa-3,5,11,16-tetraen-2-one 
• 1082395-62-7 C₄₈H₈₄O₆Si₂ 
• 1266549-20-5 C₅₇H₁₀₈O₆Si₄ 
• 939383-45-6 C₂₀H₂₄F₆IO₆P 
• 149249-91-2 (3R,4S)-1-benzoyl-4-phenyl-3-(triethylsilyl)oxy-2-azetidinone 

Relevant articles and documents

Total synthesis and biological evaluation of a series of macrocyclic hybrids and analogues of the antimitotic natural products dictyostatin, discodermolide, and taxol

The design, synthesis, and biological evaluation of a series of hybrids and analogues of the microtubule-stabilizing anticancer agents dictyostatin, discodermolide, and taxol is described. A 22-membered macrolide scaffold was prepared by adapting earlier